Background: Hepatitis C virus (HCV) is a major cause of chronic liver disease, including cirrhosis and liver cancer. The aim of our study was to determine whether IL28B single nucleotide polymorphisms (SNPs) rs12979860 and rs8099917 can be considered a prognostic host factor in untreated chronic HCV patients. Methods: We set up a real-time Allele Specific PCR amplification to determine the allele present in each polymorphic site, and statistically grouped and compared this result with clinical data. Results: We determined rs12979860 and rs8099917 genotype and allele frequencies in a single cohort of untreated chronically HCV-infected patients. We found significant associations between higher inflammatory activity, measured as ALT levels or METAVIR scores and rs12979860 CC (P = 0.0013 and P = 0.0033, respectively) and rs8099917 TT (P = 0.0005 and P = 0.0264, respectively) genotypes. Interestingly, considering both genotypes together, we also found association with ALT levels (P = 0.0003; OR = 5.125) or METAVIR scores (P = 0.0038; OR = 5.179), suggesting and additive effect on liver inflammation in these patients. Conclusion: we show association between hepatic inflammatory activity in a single Argentinean untreated chronically HCV cohort and SNPs located in the interferon lambda gene region. The studied polymorphisms, together with further innate and adaptive immune responses, clearly play a role in modulating the HCV infected patients outcome, contributing to hepatic inflammation and possible fibrosis/cirrhosis. 
Introduction
Chronic hepatitis C is a liver disease caused by the hepatitis C virus (HCV), a blood-borne virus mostly transmitted through unsafe injection practices, but also from inadequate sterilization of medical equipment, or unscreened blood and blood products. HCV can cause both, self limited and chronic infections, ranging in severity from a mild, few weeks lasting illness, to a serious, lifelong illness.
Based on World Health Organization reports, 150 million people are infected with chronic hepatitis C (approximately 600,000 in Argentine), and around 500,000 people die each year from hepatitis C-related liver diseases [1] . Unfortunately a vaccine for hepatitis C is not currently available. Early diagnosis of the HCV infection is rare. Those people who go on to develop chronic HCV infection remain undiagnosed, often until serious liver damage has developed. Although many direct acting antivirals have been developed in recent years, these are not widely available. The most widespread standard treatment at the moment is interferon alpha plus ribavirin. The success of such therapy depends on host and virus factors [2] . The degree of liver damage, measured by liver biopsies or through a variety of non-invasive tests, together with the determination of HCV genotype, is used to guide therapeutic decisions and management of the disease, to determine the most appropriate approach for each patient. In order to contribute to decisions related to the course of treatment, several groups working in Genome Wide Association Studies identified Single Nucleotide Polymorphisms (SNPs) associated to the outcome of antiviral therapy in chronic HCV patients [3] [4] [5] [6] [7] . Among them the SNPs rs12979860 and rs8099917
showed the most significant statistical relevance. These SNPs that were also associated with spontaneous virus clearance in acute infection [8] [9] [10] , and appeared to modify the natural course of disease [11] , are located close to the IL28B locus, containing a gene coding for interferon lambda 3 (IFN-λ3) that belongs to the type III interferon-family [12] . However, it is unclear how these SNPs affect transcription or protein expression. Regarding IFN-λs, these are known to be able to inhibit virus replication [13] [14] , including HCV [15] , and share with type I interferon a similar anti-viral effect. The role of these SNPs in the host inflammatory response and evolution of chronic infection in untreated chronic HCV patients is not well understood. Recent studies yielded contradictory results and have shown rs12979860 CC (or rs8099917 TT) association with more advanced fibrosis or cirrhosis [16] [17] and worse clinical outcomes [18] , while others have reported rs12979860 TT (or rs8099917 GG) to be associated with more advanced fibrosis or cirrhosis [19] IL28B genotype with fibrosis [22] . The aim of our study was to determine whether SNPs rs12979860 and rs8099917 can be considered a prognostic host factor in untreated chronically HCV-infected patients from an Argentine cohort, by analyzing host haplotypes involved in modulation of patient's immune responses.
Materials and Methods

Study Design
The study was designed and performed (years 2015-2017) using samples stocked during routine medical practice. The study has been approved by the Research and Ethics Committee at both involved centers and performed in accordance with the ethical standards adopted in the Declaration of Helsinki and revised forms. Informed consent was obtained from all donors.
Subjects
Samples from 150 HCV chronically infected patients were included. All individuals were aged ≥ 18 years, and patients were not undergoing any kind of HCV antiviral therapy. Exclusion criteria included alcohol intake greater than 20 g day −1 , history of organ transplantation, creatinine clearance < 50 mL min 
Genotype Determination
Genomic DNA was obtained from blood samples using the standard method of Primer sets yielded a single product of the correct size with their specific DNA templates and no or extremely retarded amplification with the unspecific alleles.
Histological Parameters
Liver biopsies were obtained from patients, simultaneously with peripheral blood 
Statistics
Association between liver inflammatory activity and SNPs was studied with
Fisher exact and Chi square tests. Analysis was performed with GraphPad Prism 3.0 (GraphPad Software). P values were considered significant when lower than 0.05. Odds ratios (OR) were determined using the following formula: OR = AxD/BxC, being A the number of patients harboring the studied allele and B the number of patients not harboring the studied allele, both with high inflammatory activity, C, the number of patients harboring the studied allele and D the number of patients not harboring the studied allele, both with low inflammatory activity.
Results
Clinical Features of Patients
A total of 150 untreated chronic HCV-infected patients were included. Clinical features are summarized in Table 1 . Sixty-two percent were males, with a mean age of 48.9 ± 9.8 years (range 19 -76 years old). The date of infection could be estimated for 37 patients (25%) being the use of unsafe injections the main infection route (34 patients, 23% 
rs12979860 and rs8099917
For rs12979860 the most frequent allele presented a base C at the polymorphic position (60%), being the heterozygous CT genotype the most frequent (45%). Allele:
For rs8099917, allele T was the most represented in samples (63%). Both TT and TG genotypes were equally represented (42%), (Table 2(a)). Alleles C (rs12979860) and T (rs8099917) were coincident in 88% of cases, whereas alleles T (rs12979860) and G (rs8099917) were present together in 75% of cases (Table 2 (b)).
SNPs rs12979860 and rs8099917 and Inflammatory Activity
The ALT levels were abnormal in 67% of HCV patients harboring rs12979860
genotype CC, whereas this was observed in only 38% of non-CC patients (P = 0.0013; OR = 3.200; Figure 1(a) ). This association was also found when the analysis of infected patients included only the HCV genotype 1, where 75% of Figure 2 . Association of rs8099917 and inflammatory activity. SNP rs8099917 is associated with higher ALT levels in TT patients (a), but not when comparing GG vs no-GG patients (b). When using METAVIR score as inflammation indicator, statistically significant association was found in both comparisons, TT vs no-TT (c), and GG vs no-GG (d). Data were analyzed by Fisher exact test. n, P and odd ratios (OR) are indicated in each panel. Asterisks denote significance level.
genotypes and higher ALT levels, we analyzed the possible association of both polymorphisms together. 71% of HCV patients harboring genotypes CC and TT (rs12979860 and rs8099917, respectively) showed high ALT levels, in contrast to 33% of non-CC/non-TT individuals (P = 0.0003; OR = 5.125, Figure 3(a) ).
When using METAVIR scores for comparison, 68% of CC/TT patients showed higher inflammatory activity compared to 29% of non-CC/non-TT patients (P = 0.0038; OR = 5.179; Figure 3(b) ). Finally, to explore whether these relationships between studied SNPs and increased inflammatory activity could be confounded by HCV RNA levels, we compared viral load in the different rs12979860 and rs8099917 genotypes. No association was found.
In summary, SNPs rs12979860 and rs8099917 are associated with higher inflammatory activity as measured by alanine transaminase (ALT) levels and 
rs12979860 and rs8099917 and Fibrosis
As a high liver inflammatory activity can lead to fibrosis/cirrhosis, we analyzed the association of specific patient alleles with advanced fibrosis scores (F3 -F4).
The rs12979860 CC genotype was present in 33% of patients with early stage fibrosis, compared to 45% of patients with advanced fibrosis, a difference that was not statistically significant. Similar result was obtained when analyzing rs8099917
genotypes: 34% of patients harboring rs8099917 TT genotype presented early stage fibrosis, compared to 48% of patients with advanced fibrosis (Data not shown).
These results suggest that SNPs are not significantly associated with fibrosis.
Discussion
HCV faces, during chronic infection, complex mechanisms of host innate and adaptive immunity. As previously mentioned, host genetics plays an important role in the outcome of antiviral therapy [3] [4] [5] [6] [7] . We found that C and T were the most represented alleles for rs12979860 and rs8099917, respectively.
Considering the possible genotypes, we found that CT was the most represented for rs12979860 and TT and TG for rs8099917. C/T and T/G alleles (rs12979860/ rs8099917) were found together in approximately 85% of individuals, suggesting a strong linkage and inheritance as a haplotype, as has been previously reported [3] . However, the allele frequency of rs8099917 differs between populations worldwide, so this linkage may vary between diverse cohorts [24] . A study carried out in a Spanish cohort showed similar results for rs12979860 allele C frequency [8] . Our results are consistent with a previous report [7] in Argentine patients of European ancestry, and to our knowledge, the first report with such a genetic analysis on a single Latin-American cohort in untreated HCV-infected patients. Furthermore, we show for the first time an association between hepatic inflammatory activity in a single Argentine cohort of untreated chronically HCV-infected patients and single nucleotide polymorphisms located close to IFN-λ3. The association we described here was neither dependent on HCV genotype nor confounded by viral load. The immune response to HCV infection is established and modulated by liver-infiltrated immune cells [25] . The hepatic inflammatory activity is a clinically useful tool to follow such response, through the measurement of ALT levels as well as through the analysis of liver biopsies.
In the untreated chronically HCV infected patients we found a statistically significant association between a higher inflammatory activity grade and the rs12979860 CC genotype. Previous studies have shown that this genotype was also associated with a better response to pegylated interferon-alpha and ribavirin
[12] and with spontaneous virus clearance [9] . In our group of untreated patients we found a significant association with a higher inflammatory activity grade for the rs8099917 TT genotype. Further, considering both genotypes together (rs12979860 CC and rs8099917 TT), we also found this association to be significant, suggesting and additive effect on liver inflammation in patients harboring both genotypes. As these polymorphisms are close to IFN-λ3, which has been involved in the modulation of antiviral responses [13] [26] [27] [28], our results, in agreement with a recent report concluding that IFN-λ3 rather than IFN-λ4 likely mediates haplotype-dependent hepatic inflammation and fibrosis [29] , support the hypothesis that this interferon is contributing to a stronger immune response to HCV during the acute infection phase, favoring the spontaneous clearance. Moreover, they also suggest a role for this cytokine in the chronic infection inducing a favorable outcome to the antiviral therapy. For those untreated patients who entered into a chronic phase the presence of these genotypes clearly favor an inflammatory liver state. While other groups have reported similar findings [11] [18], our study further confirm and extend the knowledge on the field through the analysis of a single cohort recruited in a specialized unit where all parameters were evaluated by a single pan- outcome. In some of such patients, rs12979860 CC and rs8099917 TT genotypes will contribute to a spontaneous or treatment-induced clearance of the virus. In other cases, particularly on those that will develop chronic infection, the same genotypes will contribute to hepatic inflammation and possibly fibrosis/cirrhosis.
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